TCBP - TC Biopharm slips on receiving Nasdaq non compliance notice
- TC Biopharm ( NASDAQ: TCBP ) has received Nasdaq notice indicating the company has not regained compliance with the rule of $35M minimum market value of listed securities.
- The company on July 15,2022 had received written Nasdaq notice indicating that the company was no longer in compliance with the MVLS Requirement and had a period of 180 calendar days, or until January 11, 2023, to regain compliance.
- The company intends to request a hearing which will stay the suspension or delisting action pending the hearing and the expiration of any extension period granted by the Panel following the hearing.
- Shares are trading down 11% .
For further details see:
TC Biopharm slips on receiving Nasdaq non compliance notice